The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

mc2d: Tools for Two-Dimensional Monte-Carlo Simulations

A complete framework to build and study Two-Dimensional Monte-Carlo simulations, aka Second-Order Monte-Carlo simulations. Also includes various distributions (pert, triangular, Bernoulli, empirical discrete and continuous).

Version: 0.2.0
Depends: R (≥ 2.10.0), mvtnorm
Imports: stats, grDevices, graphics, utils, ggplot2, ggpubr
Suggests: fitdistrplus, survival, testthat (≥ 3.0.0)
Published: 2023-07-17
Author: Regis Pouillot [aut, cre], Marie-Laure Delignette-Muller [ctb], Jean-Baptiste Denis [ctb], Yu Chen [ctb], Arie Havelaar [ctb]
Maintainer: Regis Pouillot <rpouillot at yahoo.fr>
License: GPL-2 | GPL-3 [expanded from: GPL (≥ 2)]
NeedsCompilation: no
Citation: mc2d citation info
Materials: README NEWS
In views: Distributions
CRAN checks: mc2d results

Documentation:

Reference manual: mc2d.pdf
Vignettes: A Manual for mc2d: Tools for Two-Dimensional Monte-Carlo Simulations
Case study: L. monocytogenes in cold-smoked salmon

Downloads:

Package source: mc2d_0.2.0.tar.gz
Windows binaries: r-devel: mc2d_0.2.0.zip, r-release: mc2d_0.2.0.zip, r-oldrel: mc2d_0.2.0.zip
macOS binaries: r-release (arm64): mc2d_0.2.0.tgz, r-oldrel (arm64): mc2d_0.2.0.tgz, r-release (x86_64): mc2d_0.2.0.tgz, r-oldrel (x86_64): mc2d_0.2.0.tgz
Old sources: mc2d archive

Reverse dependencies:

Reverse depends: AnnuityRIR, CopulaREMADA, CPP, OSCV, stratifyR
Reverse imports: CloneSeeker, handwriter, iCARH, rriskDistributions, RSurveillance, Umpire
Reverse suggests: decisionSupport, fitdistrplus, fitteR, sensitivity

Linking:

Please use the canonical form https://CRAN.R-project.org/package=mc2d to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.